Related Experiment Video
Updated: Jun 26, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
COVID-19 exacerbating ESRD induced pericardial effusion requiring pericardial window: A case report
Aryaan Khan1, Michael L Hudson2, Tyler R Petree2
1University of Medicine and Health Sciences, Saint Kitts and Nevis.
Insights
Recurrent pericardial effusion in end-stage renal disease (ESRD) patients, especially post-transplant and with COVID-19, can be effectively managed. A sub-xiphoid pericardial window procedure prevents cardiac tamponade.
Area of Science:
- Cardiology
- Nephrology
- Infectious Diseases
Background:
- Pericardial effusion can lead to life-threatening cardiac tamponade.
- Recurrent effusions often require surgical intervention, such as pericardial windows.
- End-stage renal disease (ESRD) is a known risk factor for pericardial effusion.
Observation:
- A 53-year-old male with ESRD and post-renal transplant experienced recurrent pericardial effusion.
- The effusion was exacerbated by a concurrent COVID-19 infection.
- The patient presented an uncommon clinical scenario requiring prompt management.
Findings:
- Successful management of recurrent pericardial effusion was achieved using a sub-xiphoid pericardial window and right-sided thoracostomy.
- This case highlights the successful surgical drainage of pericardial effusion in a complex patient profile.
- Limited case reports exist for this specific combination of conditions.
Implications:
- COVID-19 infection can significantly worsen pericardial effusion in ESRD patients, particularly those post-transplant.
- Sub-xiphoid pericardial window remains a crucial and effective procedure for managing recurrent pericardial effusion and preventing cardiac tamponade.
- This case underscores the importance of considering infectious triggers in patients with ESRD and pericardial effusion.
Introduction:
Pericardial effusion can lead to cardiac tamponade requiring immediate management. Pericardial windows are an effective measure to surgically drain recurrent effusions.
Presentation Of Case:
We present a case of a 53-year-old male with recurrent pericardial effusion secondary to ESRD and exacerbated by COVID-19 infection, describing the successful management of an uncommon clinical scenario. A sub-xiphoid pericardial window and right sided thoracostomy was performed.
Discussion:
There are limited case reports highlighting recurrent pericardial effusion management, secondary to ESRD and COVID-19 in a post renal transplant patient, through a subxiphoid pericardial window.
Conclusion:
COVID-19 infection can exacerbate pericardial effusion in a patient with ESRD, post renal transplant. Preventing cardiac tamponade, a sub-xiphoid pericardial window remains an effective measure in treating recurrent pericardial effusion.
More Related Videos
Related Concept Videos
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

